Perfect ALKemy: Optimizing the Use of ALK-Directed Therapies in Lung Cancer

nork Politi, Katerina, Gettinger, Scott
Argitaratua izan da Clin Cancer Res (2014)

PD-1 axis inhibitors in EGFR and ALK Driven Lung Cancer: Lost cause?

nork Gettinger, Scott, Politi, Katerina
Argitaratua izan da Clin Cancer Res (2016)

Current status of vandetanib (ZD6474) in the treatment of non-small cell lung cancer

nork Flanigan, Jaclyn, Deshpande, Hari, Gettinger, Scott
Argitaratua 2010

Axitinib: The evidence of its potential in the treatment of advanced thyroid cancer

nork Deshpande, Hari A, Gettinger, Scott, Sosa, Julie Ann
Argitaratua 2010

Immuno-thermal ablations – boosting the anticancer immune response

nork Slovak, Ryan, Ludwig, Johannes M., Gettinger, Scott N., Herbst, Roy S., Kim, Hyun S.
Argitaratua izan da J Immunother Cancer (2017)

Late recurrence of basaloid carcinoma initially treated as a small cell lung cancer

nork Shumaster, Vladimir, Bae, Jason W., Gettinger, Scott N., Cai, Guoping, Kim, Anthony W.
Argitaratua 2013

SOX2-specific adaptive immunity and response to immunotherapy in non-small cell lung cancer

nork Dhodapkar, Kavita M, Gettinger, Scott N, Das, Rituparna, Zebroski, Henry, Dhodapkar, Madhav V
Argitaratua 2013

Oncolytic virus immunotherapy: future prospects for oncology

nork Raja, Junaid, Ludwig, Johannes M., Gettinger, Scott N., Schalper, Kurt A., Kim, Hyun S.
Argitaratua izan da J Immunother Cancer (2018)

Precipitation of Autoimmune Diabetes With Anti-PD-1 Immunotherapy

nork Hughes, Jing, Vudattu, Nalini, Sznol, Mario, Gettinger, Scott, Kluger, Harriet, Lupsa, Beatrice, Herold, Kevan C.
Argitaratua izan da Diabetes Care (2015)

Cryotherapy for nodal metastasis in NSCLC with acquired resistance to immunotherapy

nork Adam, Lucas C., Raja, Junaid, Ludwig, Johannes M., Adeniran, Adebowale, Gettinger, Scott N., Kim, Hyun S.
Argitaratua izan da J Immunother Cancer (2018)

Distinct immunologic changes in vivo following combination versus individual PD-1 or CTLA-4 checkpoint blockade in human cancer

nork Dhodapkar, Kavita, Verma, Rakesh, Sznol, Mario, Boddupalli, Chandra Sekhar, Gettinger, Scott, Kluger, Harriet, Dhodapkar, Madhav, Das, Rituparna
Argitaratua izan da J Immunother Cancer (2014)

An Advanced Practice Nurse Coordinated Multidisciplinary Intervention for Patients with Late-Stage Cancer: A Cluster Randomized Trial

nork McCorkle, Ruth, Jeon, Sangchoon, Ercolano, Elizabeth, Lazenby, Mark, Reid, Amanda, Davies, Marianne, Viveiros, Diane, Gettinger, Scott
Argitaratua izan da J Palliat Med (2015)

Preliminary safety, pharmacokinetics, and efficacy of regorafenib, cisplatin, and pemetrexed in patients with advanced non-squamous non-small cell lung cancers

nork Hellmann, Matthew D, Sturm, Isrid, Trnkova, Zuzana Jirakova, Lettieri, John, Diefenbach, Konstanze, Rizvi, Naiyer A., Gettinger, Scott N.
Argitaratua izan da Clin Lung Cancer (2015)

Expression and clinical significance of PD-L1, B7-H3, B7-H4 and TILs in human small cell lung Cancer (SCLC)

nork Carvajal-Hausdorf, Daniel, Altan, Mehmet, Velcheti, Vamsidhar, Gettinger, Scott N., Herbst, Roy S., Rimm, David L., Schalper, Kurt A.
Argitaratua izan da J Immunother Cancer (2019)

Comparison of Survival Rates After a Combination of Local Treatment and Systemic Therapy vs Systemic Therapy Alone for Treatment of Stage IV Non–Small Cell Lung Cancer

nork Uhlig, Johannes, Case, Meaghan Dendy, Blasberg, Justin D., Boffa, Daniel J., Chiang, Anne, Gettinger, Scott N., Kim, Hyun S.
Argitaratua izan da JAMA Netw Open (2019)

Biomarkers associated with beneficial PD-1 checkpoint blockade in non-small-cell lung cancer (NSCLC) identified using high-plex digital spatial profiling

nork Zugazagoitia, Jon, Gupta, Swati, Liu, Yuting, Fuhrman, Kit, Gettinger, Scott, Herbst, Roy, Schalper, Kurt A., Rimm, David L.
Argitaratua izan da Clin Cancer Res (2020)

High SOX2 Levels Predict Better Outcome in Non-Small Cell Lung Carcinomas

nork Velcheti, Vamsidhar, Schalper, Kurt, Yao, Xiaopan, Cheng, Huan, Kocoglu, Mehmet, Dhodapkar, Kavita, Deng, Yanhong, Gettinger, Scott, Rimm, David L.
Argitaratua 2013

Treatment of Stage IV Non-small Cell Lung Cancer: Diagnosis and Management of Lung Cancer, 3rd ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines

nork Socinski, Mark A., Evans, Tracey, Gettinger, Scott, Hensing, Thomas A., VanDam Sequist, Lecia, Ireland, Belinda, Stinchcombe, Thomas E.
Argitaratua izan da Chest (2013)

Immune-related sarcoidosis observed in combination ipilimumab and nivolumab therapy

nork Suozzi, Kathleen C., Stahl, Maximilian, Ko, Christine J., Chiang, Anne, Gettinger, Scott N., Siegel, Mark D., Bunick, Christopher G.
Argitaratua izan da JAAD Case Rep (2016)

Clinical and Histologic Features of Lichenoid Mucocutaneous Eruptions Due to Anti–Programmed Cell Death 1 and Anti–Programmed Cell Death Ligand 1 Immunotherapy

nork Shi, Veronica J., Rodic, Nemanja, Gettinger, Scott, Leventhal, Jonathan S., Neckman, Julia P., Girardi, Michael, Bosenberg, Marcus, Choi, Jennifer N.
Argitaratua izan da JAMA Dermatol (2016)